BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

PriCara™ 

1000 U.S. Route 202 South

Raritan  New Jersey  08869  U.S.A.
Phone: 800-526-7736 Fax: n/a


SEARCH JOBS








 Company News
PriCara™: Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients With Chronic Low Back Pain 9/27/2010 8:54:54 AM    More...
PriCara™, Ortho-McNeil-Janssen Pharmaceuticals, Inc.: Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by Pain Practice 7/19/2010 8:21:30 AM    More...
PriCara™'s Data Comparing NUCYNTA(R) (tapentadol) Tablets to Oxycodone Immediate Release Tablets Presented at 2010 American Pain Society 5/7/2010 10:44:50 AM    More...
PriCara™ Tapentadol Data to Be Presented at 2010 American Pain Society Annual Meeting 5/3/2010 12:27:39 PM    More...
PriCara™: NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe Acute Pain 6/23/2009 9:40:00 AM    More...
PriCara™ Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches 1/2/2009 6:46:02 AM    More...
PriCara™ Release: U.S. Federal Circuit Court of Appeals Rules Patent for ACIPHEX(R) Valid and Enforceable 7/22/2008 7:23:39 AM    More...
PriCara™ Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches 2/12/2008 11:23:48 PM    More...

//-->